Literature DB >> 32236843

Effects of Estrogen on Cardiac mRNA and LncRNA Expression Profiles in Hypertensive Mice.

Jingkang Zhu1, Huan Wang2, Hui Chen3,4.   

Abstract

Estrogen is a vascular protection factor and plays a protective role in the pathogenesis of gender differences in cardiovascular diseases. This study was to address the possible mechanisms that may explain the relationship between estradiol configuration-17β-estradiol (E2) and ventricular remodeling. Here, we show that a total of 1499 LncRNAs and 680 mRNAs significantly differently expressed were identified. This result indicates that estradiol has a global role in regulating heart gene expression profiles in female mice. Go and Pathway functional cluster analysis showed that the antagonism of E2 on cardiac remodeling and AngII-induced pathological changes in female mice may be related to physiological processes such as circadian rhythm disorder and ion channel dysfunction. Graphical Abstract.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Estrogen; Heart and kidney remodeling; Hypertension; LncRNA; RAAS

Mesh:

Substances:

Year:  2020        PMID: 32236843     DOI: 10.1007/s12265-020-09990-7

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  43 in total

1.  Role of female sex hormones in the development and reversal of dahl hypertension.

Authors:  C Hinojosa-Laborde; D L Lange; J R Haywood
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

2.  Sex differences in the development of angiotensin II-induced hypertension in conscious mice.

Authors:  Baojian Xue; Jaya Pamidimukkala; Meredith Hay
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-12-30       Impact factor: 4.733

3.  Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits?

Authors:  Matthias Barton; Matthias R Meyer; Elvira Haas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08       Impact factor: 8.311

4.  Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury.

Authors:  Li Yang; Tatiana Y Besschetnova; Craig R Brooks; Jagesh V Shah; Joseph V Bonventre
Journal:  Nat Med       Date:  2010-05-02       Impact factor: 53.440

Review 5.  Recent progress in signal transduction research of the angiotensin II type-1 receptor: protein kinases, vascular dysfunction and structural requirement.

Authors:  Hiroyuki Suzuki; Evangeline D Motley; Gerald D Frank; Hirotoshi Utsunomiya; Satoru Eguchi
Journal:  Curr Med Chem Cardiovasc Hematol Agents       Date:  2005-10

6.  Sex chromosome effects unmasked in angiotensin II-induced hypertension.

Authors:  Hong Ji; Wei Zheng; Xie Wu; Jun Liu; Carolyn M Ecelbarger; Rebecca Watkins; Arthur P Arnold; Kathryn Sandberg
Journal:  Hypertension       Date:  2010-03-15       Impact factor: 10.190

Review 7.  Reactive oxygen species as mediators of angiotensin II signaling.

Authors:  K K Griendling; M Ushio-Fukai
Journal:  Regul Pept       Date:  2000-07-28

8.  Cooperation of SRC-1 and p300 with NF-kappaB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells.

Authors:  Saurabh Sahar; Marpadga A Reddy; Cynthie Wong; Li Meng; Mei Wang; Rama Natarajan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-05-10       Impact factor: 8.311

Review 9.  The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series).

Authors:  Bradley A Maron; Jane A Leopold
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

10.  Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis.

Authors:  F J Miller; D D Gutterman; C D Rios; D D Heistad; B L Davidson
Journal:  Circ Res       Date:  1998-06-29       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.